Ge Long Hui A P P·2025-11-27 11:15Core Viewpoint - Baiyunshan (600332.SH) announced that its subsidiary, Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd., has had its land and fixed assets included in the land reserve implementation plan for the Baiyun Tonghe area, indicating a strategic move to enhance its asset base and operational capacity [1] Group 1: Land Acquisition Details - The land in question is located at 355 Shatai North Road, Baiyun District, Guangzhou [1] - A compensation agreement for the state-owned land use rights was signed on November 27, 2025, with the Baiyun District People's Government [1] - The total compensation amount for the land acquisition is approximately 375,244,134 RMB [1] Group 2: Financial Implications - The land will meet the "net land" standard, allowing the company to receive an additional land transfer reward of about 73,323,768 RMB [1] - The total financial benefit from the land acquisition, including both compensation and rewards, amounts to approximately 448,567,902 RMB [1] - The company and Guanghua Pharmaceutical will process the compensation according to relevant accounting standards [1]